Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ) is a Healthcare stock tracked by StreetAlpha. It last closed at $252.93 on Oct 5, down 1.25% on the day. JNJ reports earnings on Tue, Oct 13, 2026, before the open. The average 12-month price target from 11 analysts is $291.73 (+15.3% from the last close), with a high of $320.00 and a low of $263.00. Analyst consensus is Strong Buy, based on the latest ratings from 11 firms (9 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 9 whale options trades in JNJ, 56% of them bullish and 44% bearish. In the past 30 days there were 28 dark pool prints totaling $27.3M, the largest $2.8M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 11 analysts who set a price target on JNJ in the past 90 days. The average target is $291.73, with a high of $320.00 and a low of $263.00, compared with the last close of $252.93.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 6 | RBC Capital | Maintained | Buy | $290 |
| Oct 5 | Citigroup | Target raised | Buy | $298 → $303 |
| Sep 29 | JP Morgan | Maintained | Hold | $285 |
| Sep 10 | HSBC | Maintained | Buy | $320 |
| Sep 2 | UBS | Maintained | Buy | $320 |
Whale Options Flow
90DDark Pool
30DFLEX Options Activity
FLEX Flow →FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily Cboe FLEX report for unusually large, long-dated positions. Multi-leg structures, such as paired calls and puts used for financing or hedging, are listed but not counted in these totals.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether JNJ is in one of them and how their past JNJ trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered JNJ in an article yet. Here's the latest on the wider market.